This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
3/16/2023
Operator
Conference Call Operator
Good afternoon and welcome to the Eaton Pharmaceuticals' fourth quarter 2022 financial results conference call. At this time, all participants are on a listen-only mode. Following the formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the company's request. At this time, I'd like to turn it over to David Krempa, Chief Business Officer at Eaton Pharmaceuticals.
Operator
Conference Call Operator
Please proceed.
Operator
Conference Call Operator
Thank you, Operator.
You're reading a preview of the ETON Q4 2022 earnings call.
Free account.
Disclaimer